Nova Ltd SEC Filings

Nova Ltd. (NVMI) reported record Q3 2025 results, with revenue of $224.6 million (up 2% sequentially and 25% year over year). GAAP net income was $61.4 million, or $1.90 per diluted share, versus $2.14 in Q2 2025 and $1.60 in Q3 2024. Non-GAAP EPS was $2.16, compared with $2.20 in Q2 2025 and $1.74 a year ago.

Gross margin was 56.7% (57.8% in Q2 2025; 56.6% in Q3 2024). Operating expenses were $63.6 million (Q2: $61.6 million). Management cited strength in memory and advanced logic and said fourth-quarter guidance is on track, expecting 2025 to be a record year.

Balance sheet highlights show total assets of $2.31 billion (from $1.39 billion at year-end 2024). Cash and cash equivalents were $521.6 million as of September 30, 2025. During Q3, the company issued $750.0 million in convertible senior notes, contributing to higher liquidity.

Nova Ltd. (NVMI) announced it will release third quarter 2025 financial results before the Nasdaq market opens on Thursday, November 6, 2025. A conference call to review the results will be held the same day at 8:30 a.m. Eastern Time, hosted by President & CEO Gaby Waisman and CFO Guy Kizner.

Investors can join via a live webcast on Nova’s Investor Relations site. A replay will be available from November 6, 2025 to November 13, 2025, accessible by dial-in with PIN 2479711 or through the archived webcast.

Nova Ltd. (Nasdaq: NVMI) announced on October 6, 2025 that its ELIPSON® materials metrology solution was selected as Tool of Record by a leading global foundry for Gate‑All‑Around (GAA) manufacturing. The company said it has received orders and delivered several ELIPSON® tools for use in high‑volume production, signaling deployment in advanced logic node fabrication. ELIPSON® uses Raman spectroscopy for rapid, non‑destructive, in‑die nanoscale material characterization, and this selection follows recent adoption of Nova's Metrion® platform by another GAA customer. No financial terms or revenue impact were disclosed.

Form 144 for NVMI (NOVA LTD.) reports proposed and recent insider sales of ordinary shares. The notice states 1,360 ordinary shares are proposed for sale through Oppenheimer & Co. with an aggregate market value of $434,737.60 and an approximate sale date of 10/01/2025 on Nasdaq. The filer indicates those shares were acquired as restricted stock units on 06/23/2022 totaling 1,814 units and paid on that date. The filing also discloses sales by the named person during the past three months: 479 shares on 09/15/2025 for $143,221, 303 shares on 09/22/2025 for $96,960, and 549 shares on 10/01/2025 for $175,680. The form includes the standard seller representation about material nonpublic information and references Rule 10b5-1 language where applicable.

NOVA Ltd. (NVMI) Form 144 summary: An individual proposes to sell 852 ordinary shares through Oppenheimer & Co. on Nasdaq, with an aggregate market value of $263,770.68. The issuer shows 29,278,401 shares outstanding. The 852 shares were acquired as Restricted Stock Units (RSUs) on 05/18/2023 and were paid/issued on that date. The filer also reported multiple ordinary-share sales by the same person during the past three months: 135, 720, 1,390, and 479 shares on specified dates, with listed gross proceeds. The notice includes the standard attestation that the seller is not aware of undisclosed material adverse information.

NOVA Ltd. (NVMI) filing a Form 144 notifies the proposed sale of 426 ordinary shares on 09/15/2025 via Oppenheimer & Co. on Nasdaq, with an aggregate market value of $124,860.60. The filing shows 29,278,401 shares outstanding. The securities to be sold were acquired as restricted stock units on 05/18/2023 (1,704 units reported acquired). The notice also reports a prior sale within three months: Sagiv Sarit sold 1,281 ordinary shares on 09/11/2025 for gross proceeds of $358,744.05. The filer certifies there is no undisclosed material information and includes standard Rule 10b5-1/trading-plan language.

NOVA Ltd. (NVMI) filed a Form 144 reporting a proposed sale of 1,500 ordinary shares through Oppenheimer & Co. on Nasdaq with an aggregate market value of $439,650. The filing lists total outstanding shares of 29,278,401. The securities to be sold were acquired as restricted stock units on four dates in 2021–2023 totaling 1,910 shares (520, 514, 570, 306). The filer also disclosed a prior sale on 06/25/2025 of 2,051 shares for gross proceeds of $523,005. The notice includes the seller's representation that no undisclosed material adverse information is known.

Form 144 for NOVA LTD. (NVMI) reports a proposed sale of 479 ordinary shares through Oppenheimer & Co. on 09/15/2025 with an aggregate market value of $140,394.90. The filing shows 29,278,401 shares outstanding for the class. The shares to be sold were acquired as restricted stock units on 06/24/2021 (639 units). The filer also disclosed three recent transactions in the past three months by Simon Zehava: 135 shares on 06/24/2025 for $32,400, 720 shares on 06/26/2025 for $188,640, and 1,390 shares on 06/30/2025 for $391,980. The form includes the standard representation that the seller is not aware of undisclosed material information.

Form 144 notice for Nova Ltd. (NVMI): The filer reports a proposed sale of 1,281 ordinary shares through Oppenheimer & Co. Inc., listed on Nasdaq, with an aggregate market value of $356,310.15. The filing lists the total number of shares outstanding as 29,278,401 and gives an approximate sale date of 09/11/2025.

The securities to be sold were originally acquired as restricted stock units: 1,605 shares on 06/23/2022, 1,814 shares on 06/23/2022, and 1,704 shares on 05/18/2023. The filer reports no securities sold in the past three months for the account whose sale is proposed. The notice includes the standard representation that the seller is not aware of undisclosed material adverse information about the issuer.